Nanjing Vazyme Biotech Co., Ltd. (688105.SS)

CNY 23.21

(-1.9%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 5.74 Billion 6 Billion 4.6 Billion 1.61 Billion 324.33 Million 250.74 Million
Total Current Assets 4.23 Billion 4.56 Billion 4.05 Billion 1.39 Billion 232.58 Million 175.63 Million
Cash And Short Term Investments 3.48 Billion 3.26 Billion 3.45 Billion 1.01 Billion 93.82 Million 83.28 Million
Cash and Cash Equivalents 1.96 Billion 1.54 Billion 1.47 Billion 221.6 Million 93.77 Million 83.28 Million
Short Term Investments 1.51 Billion 1.71 Billion 1.97 Billion 795.65 Million 50 Thousand 8.99 Million
Net Receivables 366.03 Million 913.28 Million 345.61 Million 240.57 Million 77.22 Million 47.41 Million
Inventory 346.24 Million 364.19 Million 242.18 Million 132.37 Million 53.49 Million 28.34 Million
Other Current Assets 37.08 Million 23.76 Million 9.47 Million 5.5 Million 8.03 Million 16.59 Million
Total Non-Current Assets 1.51 Billion 1.44 Billion 556.23 Million 215.93 Million 91.74 Million 75.1 Million
Net PPE 835.55 Million 679.47 Million 308.98 Million 128.49 Million 34.65 Million 26.32 Million
Good Will And Intangible Assets 231.73 Million 180.18 Million 16.65 Million 7.42 Million 2.29 Million 690.73 Thousand
Good Will 130.49 Million 130.49 Million - - - -
Intangible Assets 101.24 Million 49.69 Million 16.65 Million 7.42 Million 2.29 Million 690.73 Thousand
Long-Term Investments 47.29 Million -1.69 Billion -1.95 Billion 62.71 Million 26.13 Million 30.97 Million
Tax Assets 106.51 Million 67.12 Million 24.87 Million 9.08 Million 27.82 Million 15.31 Million
Other Non Current Assets 294.81 Million 2.21 Billion 2.16 Billion 8.21 Million 830.94 Thousand 1.79 Million
Other Assets 1.00 1.00 1.00 - - -
Total Liabilities 1.69 Billion 1.39 Billion 479.82 Million 279.27 Million 124.31 Million 84.66 Million
Total Current Liabilities 1.51 Billion 1.15 Billion 387.26 Million 239.22 Million 108.49 Million 80.02 Million
Account Payables 146.81 Million 318.78 Million 118.75 Million 58.58 Million 16.99 Million 12.73 Million
Tax Payables 34.45 Thousand 82.76 Million 37.78 Million 45.63 Million 12.98 Million 6.87 Million
Short Term Debt 1.18 Billion 330.46 Million 31.24 Million 1.15 Million 35.68 Million 31.16 Million
Deferred Revenue 55.91 Million 214.54 Million 236.32 Million 178.69 Million 40.2 Million 6.87 Million
Other Current Liabilities 136.64 Million 290.27 Million 928.44 Thousand 799.16 Thousand 15.6 Million 29.25 Million
Total Non Current Liabilities 176 Million 239.03 Million 92.56 Million 40.04 Million 15.82 Million 4.64 Million
Long-Term Debt 106.89 Million 127.67 Million 59.93 Million 34.32 Million - -
Deferred Revenue Non Current 21.38 Million 19.25 Million 16.23 Million 15.35 Million 11.82 Million 2.07 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 46.22 Million 80.91 Million 15.52 Million -9.73 Million 3.99 Million 2.57 Million
Other Liabilities 1.00 - 1.00 1.00 - -
Total Equity 4.02 Billion 4.61 Billion 4.12 Billion 1.33 Billion 200.01 Million 166.07 Million
Stock Holders Equity 4.02 Billion 4.6 Billion 4.12 Billion 1.33 Billion 200.01 Million 166.07 Million
Common Stock 400.01 Million 400.01 Million 400.01 Million 360 Million 15.16 Million 15.01 Million
Retained Earnings 1 Billion 1.57 Billion 1.18 Billion 574.61 Million -15.48 Million -36.46 Million
Accumulated other comprehensive income 226.41 Million 222.86 Million 134.03 Million 112.9 Million 200.34 Million 187.52 Million
Common Stock Equity 4.02 Billion 4.6 Billion 4.12 Billion 1.33 Billion 200.01 Million 166.07 Million
Capital Lease Obligation 106.89 Million 127.67 Million 59.93 Million 34.32 Million - -
Total Investments 1.56 Billion 22.31 Million 18.48 Million 795.65 Million 50 Thousand 30.97 Million
Total Debt 1.28 Billion 458.14 Million 91.18 Million 1.15 Million 35.68 Million 31.16 Million
Net Debt -679.87 Million -1.08 Billion -1.38 Billion -220.45 Million -58.08 Million -52.12 Million

Balance Sheet Charts